Kerstin Rhiem

5.1k total citations · 1 hit paper
119 papers, 1.3k citations indexed

About

Kerstin Rhiem is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, Kerstin Rhiem has authored 119 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Genetics, 47 papers in Oncology and 41 papers in Cancer Research. Recurrent topics in Kerstin Rhiem's work include BRCA gene mutations in cancer (65 papers), Breast Cancer Treatment Studies (24 papers) and Cancer Genomics and Diagnostics (22 papers). Kerstin Rhiem is often cited by papers focused on BRCA gene mutations in cancer (65 papers), Breast Cancer Treatment Studies (24 papers) and Cancer Genomics and Diagnostics (22 papers). Kerstin Rhiem collaborates with scholars based in Germany, France and Netherlands. Kerstin Rhiem's co-authors include Rita K. Schmutzler, Karin Kast, Nina Ditsch, Carsten Denkert, Andreas Schneeweiß, Jens‐Uwe Blohmer, Alfons Meindl, Michael Untch, Claus Hanusch and Peter A. Fasching and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Kerstin Rhiem

111 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response

2022 136 citations Sibylle Loibl, Andreas Schneeweiß et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kerstin Rhiem Germany	19	628	406	382	218	170	119	1.3k
Florian Clatot France	24	692 1.1×	143 0.4×	461 1.2×	321 1.5×	175 1.0×	99	1.6k
Gabriella Pichert Switzerland	21	541 0.9×	478 1.2×	181 0.5×	316 1.4×	507 3.0×	46	1.5k
Pascaline Berthet France	15	425 0.7×	513 1.3×	196 0.5×	403 1.8×	210 1.2×	34	1.2k
Furio Maggiorotto Italy	20	516 0.8×	200 0.5×	534 1.4×	225 1.0×	322 1.9×	44	1.3k
Robert D. Legare United States	14	449 0.7×	233 0.6×	230 0.6×	150 0.7×	86 0.5×	35	822
Lizet E. van der Kolk Netherlands	17	322 0.5×	359 0.9×	146 0.4×	308 1.4×	337 2.0×	33	1.3k
Gunda Pristauz Austria	13	519 0.8×	137 0.3×	484 1.3×	290 1.3×	96 0.6×	22	1.0k
Arto Leminen Finland	28	538 0.9×	206 0.5×	293 0.8×	415 1.9×	264 1.6×	60	1.9k
Geraldine R. Vink Netherlands	17	405 0.6×	237 0.6×	172 0.5×	202 0.9×	175 1.0×	82	995
Marion Gauthier‐Villars France	25	838 1.3×	786 1.9×	413 1.1×	1.0k 4.7×	204 1.2×	67	2.3k

Countries citing papers authored by Kerstin Rhiem

Since Specialization

Citations

This map shows the geographic impact of Kerstin Rhiem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerstin Rhiem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerstin Rhiem more than expected).

Fields of papers citing papers by Kerstin Rhiem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerstin Rhiem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerstin Rhiem. The network helps show where Kerstin Rhiem may publish in the future.

Co-authorship network of co-authors of Kerstin Rhiem

This figure shows the co-authorship network connecting the top 25 collaborators of Kerstin Rhiem. A scholar is included among the top collaborators of Kerstin Rhiem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerstin Rhiem. Kerstin Rhiem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kautz‐Freimuth, Sibylle, Anke Steckelberg, Frank Vitinius, et al.. (2025). Factors influencing role preferences in decision-making of healthy women with BRCA1/2 pathogenic variants: subanalysis from a randomised controlled decision coaching trial. BMC Cancer. 25(1). 164–164. 1 indexed citations

Loibl, S., Michael Untch, Jens Huober, et al.. (2025). 292MO Durvalumab in combination with neoadjuvant chemotherapy in early triple-negative breast cancer (TNBC): Long-term analysis from the GeparNuevo trial. Annals of Oncology. 36. S303–S304. 1 indexed citations

Herold, N, Corinna Ernst, Britta Blümcke, et al.. (2024). Implementing mainstream genetic counseling within the area‐wide network of the German Consortium Hereditary Breast and Ovarian Cancer (GC‐HBOC): Satisfaction of primary care providers with the provided state‐of‐the‐art training by the Cologne Center. Journal of Genetic Counseling. 33(1). 206–215. 1 indexed citations

Kast, Karin, et al.. (2024). Phenotype analysis of families with TP53 germline variants at the Center for Familial Breast and Ovarian Cancer, Cologne. Cancer Medicine. 13(3). e6920–e6920. 1 indexed citations

Redaèlli, Marcus, Sibylle Kautz‐Freimuth, Anke Steckelberg, et al.. (2023). Implementierung und Evaluation eines Decision Coaching Programms für gesunde BRCA1/2 Mutationsträgerinnen – Ergebnisse der randomisierten kontrollierten EDCP-BRCA Studie. Senologie - Zeitschrift für Mammadiagnostik und -therapie. 20(2). e13–e14.

Harter, Philipp, Kerstin Rhiem, Florian Heitz, et al.. (2023). Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma Patients. Cancers. 15(9). 2534–2534. 2 indexed citations

Heitz, Florian, Beyhan Ataseven, Carsten Denkert, et al.. (2023). Implementing HRD Testing in Routine Clinical Practice on Patients with Primary High-Grade Advanced Ovarian Cancer. Cancers. 15(3). 818–818. 16 indexed citations

Scherer, Anne, et al.. (2023). Psychological distress and decision‐making factors for prophylactic bilateral mastectomy in cancer‐unaffected BRCA1/2 pathogenic variant carriers. Psycho-Oncology. 32(4). 640–648. 6 indexed citations

Wimberger, Pauline, Jens‐Uwe Blohmer, Petra Krabisch, et al.. (2023). The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy. Breast Cancer Research. 25(1). 32–32. 6 indexed citations

10.

Brédart, Anne, Antoine De Pauw, Amélie Anota, et al.. (2022). Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes: A prospective study. Clinical Genetics. 102(1). 30–39. 2 indexed citations

11.

Ataseven, Beyhan, Chiara Cassani, Marco D’Indinosante, et al.. (2022). Ovarian cancer onset across different BRCA mutation types: a view to a more tailored approach for BRCA mutated patients. International Journal of Gynecological Cancer. 33(2). 257–262. 3 indexed citations

12.

Herold, N, Martin Hellmich, Beyhan Ataseven, et al.. (2022). Satisfaction and Quality of Life of Healthy and Unilateral Diseased BRCA1/2 Pathogenic Variant Carriers after Risk-Reducing Mastectomy and Reconstruction Using the BREAST-Q Questionnaire. Genes. 13(8). 1357–1357. 6 indexed citations

13.

Brédart, Anne, Jean‐Luc Kop, Antoine De Pauw, et al.. (2022). Assessment of psychosocial difficulties by genetic clinicians and distress in women at high risk of breast cancer: a prospective study. European Journal of Human Genetics. 30(9). 1067–1075. 6 indexed citations

14.

Fischer, Christine, Hans‐Peter Sinn, Nicola Dikow, et al.. (2021). Breast cancer characteristics and surgery among women with Li‐Fraumeni syndrome in Germany—A retrospective cohort study. Cancer Medicine. 10(21). 7747–7758. 11 indexed citations

15.

Grill, Sabine, Maryam Yahiaoui‐Doktor, Maryam Basrai, et al.. (2021). Precursor fractions of neurotensin and enkephalin might point to molecular mechanisms of cancer risk modulation during a lifestyle-intervention in germline BRCA1/2 gene mutation carriers. Breast Cancer Research and Treatment. 186(3). 741–752. 4 indexed citations

16.

Link, Theresa, Jens‐Uwe Blohmer, Marianne Just, et al.. (2020). 168MO GeparX: Denosumab (Dmab) as add-on to different regimen of nab-paclitaxel (nP)-anthracycline based neoadjuvant chemotherapy (NACT) in early breast cancer (BC): Subgroup analyses by RANK expression and HR status. Annals of Oncology. 31. S308–S309. 2 indexed citations

17.

Grill, Sabine, Maryam Yahiaoui‐Doktor, Christoph Engel, et al.. (2017). Smoking and physical inactivity increase cancer prevalence in BRCA-1 and BRCA-2 mutation carriers: results from a retrospective observational analysis. Archives of Gynecology and Obstetrics. 296(6). 1135–1144. 23 indexed citations

18.

Bosse, Kristin, Monika Graeser, Axel Goßmann, et al.. (2013). Supplemental screening ultrasound increases cancer detection yield in BRCA1 and BRCA2 mutation carriers. Archives of Gynecology and Obstetrics. 289(3). 663–670. 17 indexed citations

19.

Meindl, A, Kerstin Rhiem, Christoph Engel, et al.. (2013). Clinical course and genetics of hereditary breast and ovarian cancer. mediaTUM (Technical University of Munich).

20.

Hancke, Katharina, Bettina Tóth, Wilmar Igl, et al.. (2012). Career and Family – Are They Compatible?. Geburtshilfe und Frauenheilkunde. 72(5). 403–407. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact